Mytrex Health Technologies, Inc.

TPEX:4431 Stock Report

Market Cap: NT$745.3m

Mytrex Health Technologies Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Mytrex Health Technologies.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Luxury earnings growth16.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

The Trend Of High Returns At Mytrex Health Technologies (GTSM:4431) Has Us Very Interested

Apr 01
The Trend Of High Returns At Mytrex Health Technologies (GTSM:4431) Has Us Very Interested

Could The Market Be Wrong About Mytrex Health Technologies, Inc. (GTSM:4431) Given Its Attractive Financial Prospects?

Feb 07
Could The Market Be Wrong About Mytrex Health Technologies, Inc. (GTSM:4431) Given Its Attractive Financial Prospects?

Shareholders of Mytrex Health Technologies (GTSM:4431) Must Be Delighted With Their 438% Total Return

Jan 04
Shareholders of Mytrex Health Technologies (GTSM:4431) Must Be Delighted With Their 438% Total Return

Should You Rely On Mytrex Health Technologies's (GTSM:4431) Earnings Growth?

Dec 07
Should You Rely On Mytrex Health Technologies's (GTSM:4431) Earnings Growth?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mytrex Health Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4431 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241,464-436078N/A
3/31/20241,379-501537N/A
12/31/20231,293-56-29-4N/A
9/30/20231,295-78-324N/A
6/30/20231,297-99-3412N/A
3/31/20231,384-96-342N/A
12/31/20221,472-922972N/A
9/30/20221,196-733467N/A
6/30/2022920-553962N/A
3/31/2022606-351138N/A
12/31/2021292-14-1713N/A
9/30/202148264126197N/A
6/30/2021787259209360N/A
3/31/2021905305230400N/A
12/31/20201,024352251441N/A
9/30/2020863296125270N/A
6/30/202058912351111N/A
3/31/2020494665086N/A
12/31/201939895060N/A
9/30/201943093048N/A
6/30/201945991844N/A
3/31/201947310-622N/A
12/31/201848611-290N/A
9/30/201848413-1114N/A
6/30/201848315628N/A
3/31/201848517N/A37N/A
12/31/201748820N/A46N/A
9/30/201747523N/A40N/A
6/30/201746226N/A33N/A
3/31/201744026N/A48N/A
12/31/201641827N/A62N/A
9/30/201640822N/A53N/A
6/30/201639717N/A45N/A
3/31/201640924N/A50N/A
12/31/201542231N/A55N/A
9/30/201540936N/A54N/A
6/30/201539741N/A53N/A
3/31/201539037N/A42N/A
12/31/201438334N/A32N/A
9/30/201439035N/A36N/A
6/30/201439737N/A40N/A
3/31/201439533N/A19N/A
12/31/201339428N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4431's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 4431's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4431's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4431's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4431's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4431's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y